Who Owns Fennec Pharmaceuticals Stock?
NASDAQ: FENCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 54.24%
- Held by insiders
- 14.13%
- Institutional holders
- 146
- Institutions 54.2%
- Insiders 14.1%
- Public and other 31.6%
Who owns Fennec Pharmaceuticals stock?
Institutional investors own about 54.2% of Fennec Pharmaceuticals's shares, spread across 146 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 14.13% of FENC.
The largest institutional holders are Rosalind Advisors, Inc. (9.07%), AIGH Capital Management LLC (7.07%) and Solas Capital Management, LLC (5.38%). Together, the top 10 institutions control 36.6% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their FENC positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of FENC
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Rosalind Advisors, Inc. | 3.19M | 9.07% | +9.6% |
| AIGH Capital Management LLC | 2.49M | 7.07% | +25.5% |
| Solas Capital Management, LLC | 1.89M | 5.38% | -23.9% |
| Blackrock Inc. | 1.73M | 4.92% | +26.2% |
| AWM Investment Company, Inc. | 1.16M | 3.30% | +61.1% |
| Vanguard Capital Management LLC | 839.31K | 2.39% | -6.5% |
| Prospect Capital Advisors, LLC | 497.80K | 1.42% | +100.0% |
| State Street Corporation | 426.00K | 1.21% | +18.6% |
| Geode Capital Management, LLC | 402.57K | 1.15% | +8.3% |
| Jane Street Group, LLC | 233.88K | 0.67% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of FENC
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 815.19K | 2.32% |
| iShares Trust-iShares Russell 2000 ETF | 742.19K | 2.11% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 316.47K | 0.90% |
| iShares Trust-iShares Russell 2000 Growth ETF | 274.78K | 0.78% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 149.16K | 0.42% |
| Bridgeway Funds, Inc.-Ultra-Small Company Fund | 108.00K | 0.31% |
| iShares Trust-iShares Micro-Cap ETF | 98.29K | 0.28% |
| College Retirement Equities Fd.-College Retirement Equities Fd. - Tota | 85.12K | 0.24% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 70.50K | 0.20% |
| Quantitative Master Series LLC-Master Small Cap Index Series | 50.48K | 0.14% |
Frequently asked questions
Who is the largest shareholder of Fennec Pharmaceuticals?
Rosalind Advisors, Inc. is the largest institutional shareholder of FENC, owning 9.07% of shares outstanding (3.19M shares) as of its latest 13F filing.
What percentage of Fennec Pharmaceuticals is owned by institutions?
Institutions own about 54.2% of FENC shares and 63.2% of the public float.
How much of Fennec Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 14.13% of FENC shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.